Previous studies have reported that targeting HDAC6 alleviates the phenotypes of multiple neurodegenerative mouse models,73 including AD,35, 40, 74 amyotrophic lateral sclerosis (ALS),75 and Charcot‐Marie‐Tooth disease (CMT2D).76, 77. Here, HDAC6 is linked to amyotrophic lateral sclerosis.